| Term es nes pval sidak fdr geneset_size leading_edge leading_edge_size |
| Ciliopathies 0.7371182455361807 2.7843227463561284 0.0053639630298087 0.9611696857317767 0.7276291869265892 20 Q9UBB4,O43924,O75665,Q15555,Q9NQ48,Q8NCM8,Q2M1P5,Q9Y366 8 |
| Sphingolipid pathway 0.8165506643136742 2.63840635322712 0.0083296702960051 0.9936046987525416 0.7276291869265892 10 Q9Y5P4,Q13510,O95470,Q96G23,Q9NRA0,Q06136,P04062 7 |
| Sphingolipid metabolism overview 0.8542594044268427 2.5785735136800594 0.0099209187795155 0.997575566160072 0.7276291869265892 8 Q13510,O95470,Q96G23,P27544,Q9NRA0,Q06136 6 |
| Sphingolipid metabolism integrated pathway 0.8542594044268427 2.5785735136800594 0.0099209187795155 0.997575566160072 0.7276291869265892 8 Q13510,O95470,Q96G23,P27544,Q9NRA0,Q06136 6 |
| Genes related to primary cilium development based on crispr 0.6876456176082145 2.567335318492141 0.0102483455892867 0.9980146057258 0.7276291869265892 16 Q9Y496,A0AVF1,O75665,Q9C0F1,Q9NQ48,Q8NCM8,Q96J42,Q9Y366 8 |
| Sphingolipid metabolism in senescence 0.766894402212982 2.483055810139086 0.0130260677409936 0.9996363930907308 0.7276291869265892 11 O15269,Q13510,Q96G23,P16278,Q06136,P04062 6 |
| Camkk2 pathway 0.7337794648020575 2.2382238684265605 0.0252064598982264 0.9999997989814864 0.7276291869265892 10 P09601 1 |
| Photodynamic therapyinduced nfe2l2 nrf2 survival signaling 0.8864563831314963 2.207950169737458 0.0272477469820939 0.9999999433296106 0.7276291869265892 5 P07099,P09601 2 |
| Cardiac hypertrophic response 0.6382379269751391 2.0724844154619904 0.0382202881500215 0.9999999999400664 0.7276291869265892 14 P49841,O15111,P31749,P17252,P42345,Q9Y6K9,P31751,Q16539,P50750 9 |
| Degradation pathway of sphingolipids including diseases 0.7635612409834565 2.0341067082175965 0.0419408377683023 0.9999999999942328 0.7276291869265892 7 P17900,P06865,P06280 3 |
| S1p receptor signal transduction 0.7335189382911566 2.025341735895136 0.0428322857305734 0.9999999999967132 0.7276291869265892 8 Q9NRA0,P31749,Q13510,Q9H0H5 4 |
| Fluoropyrimidine activity 0.6385696015236332 1.9838081818344089 0.0472772276916855 0.9999999999998024 0.7276291869265892 13 Q92820,P00374,P04818,Q06203,P31350 5 |
| Proteasome degradation 0.6486969921514121 1.942631713320551 0.0520606723093743 0.9999999999999906 0.7276291869265892 43 O00231,Q9UL46,P30511,P49721,P28070,P28074,P49720,P20618,P60900,P10321,P28072,P25788,P46934 13 |
| Synaptic signaling pathways associated with autism spectrum disorder 0.6420814569000859 1.919787941281092 0.0548846906601858 0.9999999999999984 0.7276291869265892 12 P49841,P31749,Q13131,P42345,P31751,P54646,Q05086 7 |
| Antiviral and antiinflammatory effects of nrf2 on sarscov2 pathway 0.8664953163953196 1.9136164054825855 0.0556691872926877 0.999999999999999 0.7276291869265892 4 P09601 1 |
| Hedgehog signaling pathway wp4249 0.6946719375303312 1.8400151810694956 0.0657660085616096 1.0 0.7276291869265892 8 Q9Y496,Q2M1P5,P48729,Q9UMX1 4 |
| Metabolism of spingolipids in er and golgi apparatus 0.8470760233918183 1.8369525082341616 0.0662169066939322 1.0 0.7276291869265892 4 Q9NRA0,Q06136,O95470 3 |
| Folate metabolism 0.5958391581498896 1.8292369958478756 0.0673641124571042 1.0 0.7276291869265892 14 Q8WTV0,P00374 2 |
| Glycosaminoglycan degradation 0.789092221863864 1.8066923486969688 0.0708102613532588 1.0 0.7276291869265892 5 P06865,P54802,P16278 3 |
| Autophagy 0.6873511626957581 1.8047135495140745 0.0711195184355104 1.0 0.7276291869265892 8 Q13131,O75143,Q9NT62,Q96B36,P54646 5 |
| Tlr4 signaling and tolerance 0.8362872688588517 1.794153901801195 0.0727886076476744 1.0 0.7276291869265892 4 Q15629 1 |
| Neuroinflammation 0.77664340535475 1.7543211418743463 0.0793754951096297 1.0 0.7548548608699421 5 Q8N9N2,O15111 2 |
| Mapk cascade 0.7721609406602834 1.735410713857637 0.0826680837443758 1.0 0.7548548608699421 5 P62993 1 |
| 4hydroxytamoxifen dexamethasone and retinoic acids regulation of p27 expression 0.6708985538664135 1.7249637827613888 0.0845339996149543 1.0 0.7548548608699421 8 P31749,Q13131,P42345,P06730,Q96KB5 5 |
| Rala downstream regulated genes 0.6944852370099566 1.716285299188424 0.0861098376305733 1.0 0.7548548608699421 7 Q8IYI6 1 |
| 7oxoc and 7betahc pathways 0.6129689626515366 1.687807950977631 0.09144810082844 1.0 0.7809999303925095 11 P34913 1 |
| Nucleotide metabolism 0.5993578763373095 1.685945571965885 0.091806283208391 1.0 0.7809999303925095 12 P00374 1 |
| Target of rapamycin tor signaling 0.6179730745986676 1.6471564634279732 0.0995258898809443 1.0 0.8132495796974265 10 P31749,P17252,Q13131,Q96B36,P54646 5 |
| Nad biosynthetic pathways 0.8762218266031261 1.6343026165244952 0.1021953245619924 1.0 0.8132495796974265 3 P43490 1 |
| Regulatory circuits of the stat3 signaling pathway 0.6505699476947945 1.6256775229350664 0.1040182740427693 1.0 0.815935552231593 8 P42345,Q16539,P40763,Q96B36 4 |
| Ethanol effects on histone modifications 0.5860961255758428 1.6124082221829266 0.106873136835093 1.0 0.8171060082075468 12 P00374 1 |
| Hostpathogen interaction of human coronaviruses apoptosis 0.7367651360046927 1.5851795331702347 0.1129255492895744 1.0 0.8420621206284317 5 P55210,Q07820,Q16539,P31749 4 |
| Proteoglycan biosynthesis 0.688432377935902 1.575471411708368 0.1151476722503717 1.0 0.8449477477876778 6 Q8TB61 1 |
| Il17 signaling pathway 0.6875137955208266 1.5713112500341526 0.1161103693151941 1.0 0.8449477477876778 6 Q9Y6K9,P49841,P40763,P31749 4 |
| Wnt signaling pathway 0.5568469576139133 1.5213026369083458 0.1281839088468062 1.0 0.8826556223155679 13 P49841,P31749,P17252,P49840,P42345,Q9BTU6,P48729 7 |
| Dna mismatch repair 0.5313187858625535 1.519827526585298 0.1285543289381787 1.0 0.8826556223155679 22 Q9NR33,Q9UQ84,P56282,P28340,Q9NRF9,P52701,Q07864,P41440,P15927,P43246 10 |
| Base excision repair 0.5249458468427252 1.513445179277472 0.1301666162911583 1.0 0.8826556223155679 20 Q9NR33,P56282,Q9NRF9,Q07864,Q9UGN5,P18887 6 |
| Metapathway biotransformation phase i and ii 0.5282152626972971 1.5001752373280313 0.1335690158684936 1.0 0.8826556223155679 22 P34913,Q16850,O43708,Q8NCH0,P07099 5 |
| Striated muscle contraction pathway 0.6713175554774989 1.4977869937834845 0.1341886010595483 1.0 0.8826556223155679 6 O43707,P67936,P09493 3 |
| Mirnas involvement in the immune response in sepsis 0.7577812601958125 1.4789893843763595 0.1391431520264785 1.0 0.8826556223155679 4 O15111 1 |
| Tnfalpha signaling pathway 0.5200011271452252 1.4649923093167998 0.1429230160206605 1.0 0.8826556223155679 21 P62993,P63208,O15111,P31749,P42574,P55210,Q9NR28,P06737,Q9Y6K9,Q16543 10 |
| Tolllike receptor signaling pathway 0.5575741982251191 1.4529587562751056 0.1462352056463642 1.0 0.8826556223155679 12 Q16539,O15111,P31749 3 |
| Cellular proteostasis 0.705176952325249 1.4499655777913292 0.1470681184749593 1.0 0.8826556223155679 5 O15212,P61758,Q9NQP4,Q9UHV9 4 |
| Joubert syndrome 0.5090278629987799 1.447104337901697 0.1478677032787185 1.0 0.8826556223155679 18 O43924 1 |
| Il9 signaling pathway 0.6135212107741836 1.442867721414168 0.1490577375433575 1.0 0.8826556223155679 8 P50750 1 |
| Nonhomologous end joining 0.7430958448629307 1.419488035516013 0.1557567825670793 1.0 0.8839187320204417 4 P12956 1 |
| Vitamin d in inflammatory diseases 0.697708914945979 1.417878669674643 0.1562261908937436 1.0 0.8839187320204417 5 Q16539,O15111 2 |
| 3q29 copy number variation syndrome 0.5508779947025526 1.4153051792342135 0.156979037117946 1.0 0.8839187320204417 12 Q8NCM8,O94888,O95684,P31749 4 |
| Estrogen signaling pathway 0.6072359861561129 1.4116545777717264 0.1580516938049796 1.0 0.8839187320204417 8 O15111,P31749,P17252,Q9Y6K9,Q16539 5 |
| Ferroptosis 0.513222413777947 1.3715973051233417 0.1701888332234244 1.0 0.9024189059144504 24 P45880,P09601 2 |
| Nanomaterial induced apoptosis 0.6175893933014078 1.3528494800681503 0.1761037216887189 1.0 0.9024189059144504 7 P42574,P55210,O95831,Q9NR28 4 |
| Resistin as a regulator of inflammation 0.5948721414250353 1.350121350091933 0.1769770610000935 1.0 0.9024189059144504 8 O15111,P31749,Q9Y6K9,P31751,Q16539 5 |
| Mammary gland development pathway pregnancy and lactation stage 3 of 4 0.6389090796840814 1.3498521269695491 0.1770634203467072 1.0 0.9024189059144504 6 P06730,O15111,P04150 3 |
| Statin inhibition of cholesterol production 0.6768765356626172 1.3282073347992858 0.1841096219760962 1.0 0.919026542756712 5 Q8WTV0 1 |
| Aryl hydrocarbon receptor pathway wp2873 0.7181286549707467 1.3181377952511515 0.187457524312304 1.0 0.9229942809742748 4 Q15185,P07900,Q16543 3 |
| Hepatitis b infection 0.5071753548401506 1.3166357308776595 0.1879607558937679 1.0 0.9229942809742748 25 Q15904,P62993,O15111,P31749,P42574,P17252,P40763,Q9Y6K9,P63104,P31751,Q16539,P31946 12 |
| Interleukin1 il1 structural pathway 0.5853124979928859 1.3024437477688242 0.192764735781842 1.0 0.9314392032978608 8 Q16539,O15111 2 |
| Melatonin metabolism and effects 0.7845659163987286 1.2813273183884957 0.2000787213141071 1.0 0.9428472599310324 3 P42892,P17252 2 |
| Phosphodiesterases in neuronal function 0.7786792675245808 1.2586475906677346 0.2081576492937999 1.0 0.9428472599310324 3 O43924 1 |
| Cytosine methylation 0.6565144672863983 1.2404384219963966 0.2148132770814315 1.0 0.9428472599310324 5 O75874 1 |
| Cholesterol biosynthesis with skeletal dysplasias 0.5908272835781178 1.2249290708880496 0.2206019460693133 1.0 0.9428472599310324 7 Q16850,Q15392 2 |
| Familial hyperlipidemia type 4 0.769407027188032 1.2229560988855597 0.2213462781782258 1.0 0.9428472599310324 3 Q9UBV2 1 |
| Aryl hydrocarbon receptor pathway wp2586 0.6050433234409689 1.1946195496602816 0.2322357075529417 1.0 0.9428472599310324 6 P07900,Q16543,O00170 3 |
| Ebsteinbarr virus lmp1 signaling 0.6437554840596742 1.18545244023591 0.2358386083056749 1.0 0.9428472599310324 5 P07900,Q9Y6K9,P28482,O15111 4 |
| Chromosomal and microsatellite instability in colorectal cancer 0.4670651961986617 1.1789578518607449 0.2384149594556572 1.0 0.9428472599310324 18 P49841,Q16611,P20585,P31749,P42574,P52701,P31751,P43246,P48729,Q96KP1 10 |
| Hostpathogen interaction of human coronaviruses autophagy 0.6794031989917558 1.1609494085763128 0.245662474092335 1.0 0.9428472599310324 4 Q9NT62,O75143 2 |
| Apoptosis 0.4567027405044221 1.147938806537404 0.250993826611813 1.0 0.9428472599310324 16 Q16611,O15111,P31749,P42574,P55210,Q07820,P98170,Q9NR28,Q9Y6K9 9 |
| Apoptosis modulation and signaling 0.4687763868023042 1.1458186718139989 0.2518701876934435 1.0 0.9428472599310324 15 O95831,P55210,Q07820,Q9NR28,O95817 5 |
| Vitamin a and carotenoid metabolism 0.5939329117602661 1.1436860946044027 0.2527538422221347 1.0 0.9428472599310324 6 Q6NUM9,Q8WTV0 2 |
| Follicle stimulating hormone fsh signaling pathway 0.5519043915260075 1.1354658917794838 0.2561801651359436 1.0 0.9428472599310324 8 P42345,Q16539,P31749,P17252 4 |
| Tnfrelated weak inducer of apoptosis tweak signaling pathway 0.4893375614101488 1.1291686398978296 0.258826700162428 1.0 0.9428472599310324 13 P49841,O15111,P31749,P42574,P55210,P31751,Q16539 7 |
| Cannabinoid receptor signaling 0.5707702547766261 1.1289680127667214 0.2589113276495929 1.0 0.9428472599310324 7 P10644,P28482,Q16539,P17252 4 |
| Methionine metabolism leading to sulfur amino acids and related disorders 0.6258645072620079 1.1084679598076623 0.2676597690127718 1.0 0.9526502230979076 5 P32929,Q99707 2 |
| Relationship between inflammation cox2 and egfr 0.6229983886337397 1.0961563913300214 0.2730103400254462 1.0 0.9526502230979076 5 P31751,P28482,P31749 3 |
| Hepatitis c and hepatocellular carcinoma 0.48285814058467 1.0914212747451186 0.275087555273112 1.0 0.9526502230979076 13 P62993,P31749,P55210,P40763,Q16539,P31350 6 |
| Micrornas in cardiomyocyte hypertrophy 0.463039352810742 1.0846622903908596 0.2780712553661861 1.0 0.9526502230979076 22 P49841,O15111,P31749,P40763,P42345,O75116,Q9Y6K9,P31751,Q16539,Q13464,P50750 11 |
| Alzheimers disease 0.5804893271059226 1.080212290887984 0.2800476563966669 1.0 0.9526502230979076 86 Q9H0B6,P04350,P21796,P45880,O75143,P49721,P05067,P20618,P28072,P28070,P49720,P25788,P33176,Q13564,P07384,O95197,Q07954,Q99436,P48729,Q9NSK0,O15111,P28074,Q07866,P60900 24 |
| Ketogenesis and ketolysis 0.5587989178182117 1.071764763764719 0.2838257034038056 1.0 0.9526502230979076 7 O43772 1 |
| Pyrimidine metabolism and related diseases 0.5777602440367235 1.0696623771720832 0.2847713069061037 1.0 0.9526502230979076 6 P27708,P04818,P31350 3 |
| Apoptosis modulation by hsp70 0.6567251461988368 1.0692820333478967 0.2849426039063425 1.0 0.9526502230979076 4 P42574,P55210,O95831 3 |
| Hostpathogen interaction of human coronaviruses interferon induction 0.5742731650625728 1.0537309995783972 0.2920060920402725 1.0 0.9526502230979076 6 O15111 1 |
| Fibrin complement receptor 3 signaling pathway 0.7243496053785607 1.050527773383367 0.2934755286343904 1.0 0.9526502230979076 3 O15111,P31749 2 |
| Nsp1 from sarscov2 inhibits translation initiation in the host cell 0.4750625934243011 1.0460552623614203 0.2955355187351953 1.0 0.9526502230979076 13 O15372,O75822,P55010 3 |
| Cholesterol biosynthesis pathway 0.4742758188702642 1.0414806720022884 0.2976525189559418 1.0 0.9526502230979076 13 Q15800 1 |
| Nucleotide excision repair 0.4685972280650045 1.0383615215996969 0.2991017765112227 1.0 0.9526502230979076 27 Q9NR33,Q13619,P56282,Q9NRF9,P28340,P54727,Q07864,P41440,P15927 9 |
| Translation factors 0.4883030418447825 1.0266296274600346 0.3045948975996706 1.0 0.9526502230979076 36 Q9NR50,P60228,O75153,P06730,O15372,Q9H074,P49770,Q14240,P55010,O75822,Q9UI10 11 |
| Wnt signaling 0.4600547642166701 1.0218758677821316 0.3068396554737327 1.0 0.9526502230979076 14 O75116,P48729,Q8TAA9,P17252 4 |
| Insulin signaling in adipocytes normal condition 0.6448251673686761 1.0214108328340037 0.3070598350876521 1.0 0.9526502230979076 4 O60343,P31751 2 |
| Insulin signaling in adipocytes diabetic condition 0.6448251673686761 1.0214108328340037 0.3070598350876521 1.0 0.9526502230979076 4 O60343,P31751 2 |
| Regulation of wnt bcatenin signaling by small molecule compounds 0.6441790423289111 1.018817412586641 0.3082896575389582 1.0 0.9526502230979076 4 Q07954,P48729 2 |
| Signal transduction through il1r 0.6427658503091518 1.0131474162085847 0.3109897527514662 1.0 0.9526502230979076 4 O15111 1 |
| Oxidative stress response 0.5640557490224017 1.0071350947939772 0.3138698582723238 1.0 0.9526502230979076 6 P09601 1 |
| Il4 signaling pathway 0.487826379541521 1.0031550259022235 0.3157860686742348 1.0 0.9536739273961892 11 P62993,Q16539,O15111 3 |
| Monoamine transport 0.6384994605836529 0.9960496082870012 0.3192260422399953 1.0 0.9558236537747962 4 Q16539,O15127 2 |
| Agerage pathway 0.4377851316440328 0.9919019309719032 0.3212453670799398 1.0 0.9558236537747962 18 O15111,P31749,P17252,P40763,P26038,Q16539,Q13464 7 |
| Thymic stromal lymphopoietin tslp signaling pathway 0.4741795206956067 0.9817420589120298 0.3262269393566543 1.0 0.965887604761859 12 P31749,P42345,P40763,Q9BTU6,Q16539 5 |
| Thyroid hormones production and peripheral downstream signaling effects 0.4311309940182413 0.9669411423312828 0.3335734577832379 1.0 0.9694447426908338 17 P62993,P17252,Q15361,Q16539,Q96B36,O60343 6 |
| Mapk and nfkb signaling pathways inhibited by yersinia yopj 0.6951183864367334 0.940221036179464 0.3471041935858237 1.0 0.9855159597682722 3 Q9Y6K9,O15111 2 |
| Tolllike receptor signaling related to myd88 0.6951183864367334 0.940221036179464 0.3471041935858237 1.0 0.9855159597682722 3 Q9Y6K9,O15111 2 |
| Erk pathway in huntingtons disease 0.6951183864367172 0.940221036179404 0.3471041935858543 1.0 0.9855159597682722 3 P42574,P55210 2 |
| Alzheimers disease and mirna effects 0.5625253925793373 0.9393691933090468 0.3475412242229172 1.0 0.9855159597682722 89 Q9H0B6,P21796,P45880,O75143,P49721,P05067,P20618,P28072,P28070,P49720,P25788,Q13564,P07384,O95197,Q07954,Q99436,Q9NSK0,O15111,P28074,Q07866,P60900 21 |
| Serotonin receptor 467 and nr3c signaling 0.6232462207454647 0.9351966757228536 0.3496869513906793 1.0 0.9869669095325716 4 P04150 1 |
| Wntbetacatenin signaling pathway in leukemia 0.5815720535946232 0.919436844119666 0.3578671252966319 1.0 1.0 5 P48729,P31749 2 |
| Nonsmall cell lung cancer 0.4312098608050252 0.9160817666760614 0.3596240102978116 1.0 1.0 20 P62993,Q16611,P11802,P31749,P42574,P17252,P40763,P31751,Q13043,P28702 10 |
| Tcell receptor tcr signaling pathway 0.4245848093771714 0.8911542192974924 0.3728464408343677 1.0 1.0 19 P62993,P46108,O15111 3 |
| Bile acids synthesis and enterohepatic circulation 0.6794053629086968 0.8817092550051809 0.3779340548378815 1.0 1.0 3 P51114 1 |
| Neovascularisation processes 0.6765318201515498 0.8710809954473265 0.3837099300548243 1.0 1.0 3 P31749 1 |
| Ranklrank signaling pathway 0.415885629043094 0.8704652054490902 0.384046226060281 1.0 1.0 17 O15111,P31749,P42345,Q9Y6K9,P31751,Q16539 6 |
| Cholesterol metabolism with bloch and kandutschrussell pathways 0.4368316671726294 0.8695096759133247 0.384568418009529 1.0 1.0 25 Q16850,Q15392,Q15800 3 |
| Tca cycle nutrient use and invasiveness of ovarian cancer 0.6708548688384737 0.8501559847326001 0.3952383691983809 1.0 1.0 3 P40763 1 |
| Leptininsulin signaling overlap 0.6680333513619403 0.839793178737551 0.4010243587154527 1.0 1.0 3 P31749 1 |
| Familial hyperlipidemia type 3 0.8644067796610292 0.8366626654285274 0.4027822105039869 1.0 1.0 2 Q8WTV0 1 |
| Familial hyperlipidemia type 5 0.8644067796610138 0.836662665428476 0.4027822105040157 1.0 1.0 2 Q9UBV2 1 |
| Familial hyperlipidemia type 1 0.8644067796610138 0.836662665428476 0.4027822105040157 1.0 1.0 2 Q9UBV2 1 |
| Purine metabolism 0.4738059374282214 0.8353621932680488 0.4035138097698163 1.0 1.0 9 P20839,P00813 2 |
| Estrogen receptor pathway 0.6664717918737186 0.8340689392731025 0.4042421369611606 1.0 1.0 3 P40763,Q15067 2 |
| Pathways of nucleic acid metabolism and innate immune sensing 0.5575933185762443 0.8188465843748395 0.4128739488495969 1.0 1.0 5 O00584 1 |
| Vitamin d metabolism 0.5934277353865264 0.8178596213488589 0.4134373491063634 1.0 1.0 4 P04062,P28702 2 |
| Pdgfrbeta pathway 0.486052501872462 0.8089302333627209 0.4185552774007819 1.0 1.0 8 P62993,P17252 2 |
| Adipogenesis 0.4058806040563069 0.8077342145425646 0.4192436028789919 1.0 1.0 17 P14174,Q16822,P43490,O75844 4 |
| Purine metabolism and related disorders 0.4237275332668072 0.8063398978195002 0.4200468914247484 1.0 1.0 14 P20839,P00813,Q06203 3 |
| Transcription factor regulation in adipogenesis 0.8533021624780952 0.7993687114973616 0.4240766474106809 1.0 1.0 2 Q16822 1 |
| Peroxiredoxin 2 induced ovarian failure 0.6559818234397838 0.7958306249599836 0.426130488818309 1.0 1.0 3 Q9UGN5 1 |
| Il7 signaling pathway 0.482572144056841 0.7919678754189737 0.4283794078130776 1.0 1.0 8 P49841,P40763,P31749 3 |
| Head and neck squamous cell carcinoma 0.4210799302780112 0.7908440456619932 0.4290350036440338 1.0 1.0 14 P11802,P31749,P06730,P31751,P54646 5 |
| Egfr tyrosine kinase inhibitor resistance 0.4024111512038524 0.7861180000160035 0.431798359886399 1.0 1.0 17 P62993,P49841,P31749,P17252,P40763,P42345,P06730,P31751,O60573 9 |
| Cohesin complex cornelia de lange syndrome 0.3951279929424608 0.7578697323695173 0.4485289716749721 1.0 1.0 16 P30154,Q9Y6X3,P30153 3 |
| Il3 signaling pathway 0.4236579383032214 0.7507098821702207 0.4528272743964379 1.0 1.0 13 P62993,P31946,P31749,P17252 4 |
| T cell receptor and costimulatory signaling 0.4730901886553704 0.7460083560228283 0.4556623673508624 1.0 1.0 8 P17252,P49840,P48729,P31749 4 |
| Vitamin d receptor pathway 0.4082154246930127 0.7161583171212014 0.4738935978501257 1.0 1.0 14 P20020,Q92783 2 |
| Complement system in neuronal development and plasticity 0.4166699988483267 0.7114838551979197 0.4767844519327679 1.0 1.0 13 Q5KU26,P42574,P55210,P98170,Q9NR28 5 |
| B cell receptor signaling pathway 0.3985976443643496 0.6967780195332427 0.4859417239038721 1.0 1.0 21 P62993,O15111,P49840,Q16539,P60033,P46108 6 |
| Oncostatin m signaling pathway 0.3876743256582 0.6952745994271207 0.4868832293658891 1.0 1.0 17 P62993,P31749,P42574,P55210,P17252,P40763,P42345,Q16539 8 |
| Interferon type i signaling pathways 0.386759768175542 0.6896961766068218 0.4903852707600866 1.0 1.0 17 Q53EL6,Q16539,P06730,P46108 4 |
| Chemokine signaling pathway 0.4115097244251534 0.6818952810886849 0.495305169507839 1.0 1.0 27 P62993,P49841,O15111,P31749,O75116,P31751,Q13464,P46108 8 |
| Congenital generalized lipodystrophy cgl 0.817066043249568 0.6809474950769012 0.495904713782296 1.0 1.0 2 P62993 1 |
| Praderwilli and angelman syndrome 0.4392245328503379 0.6600525412679924 0.5092201127450844 1.0 1.0 9 Q05086,Q7L576,P11802 3 |
| Vitamin dsensitive calcium signaling in depression 0.5168062233375308 0.652734242903766 0.5139276225846006 1.0 1.0 5 P20020 1 |
| Tcell antigen receptor tcr pathway during staphylococcus aureus infection 0.4044277147498484 0.6436104078217904 0.519828099515824 1.0 1.0 13 P62993,P31749,P11802,O15111 4 |
| Regulation of apoptosis by parathyroid hormonerelated protein 0.4495399675845761 0.6338401839311063 0.5261851256101233 1.0 1.0 8 P49841,Q07820,P49840,P31749 4 |
| Transcription factors regulate mirnas related to cardiac hypertrophy 0.54193688438065 0.6230911074626552 0.5332246530410718 1.0 1.0 4 P31751,P31749 2 |
| Mevalonate pathway 0.5048289969170581 0.6056033054618244 0.5447782068463889 1.0 1.0 5 Q9BWD1 1 |
| Angiopoietinlike protein 8 regulatory pathway 0.406064008184843 0.6048579447942932 0.545273388561587 1.0 1.0 30 P49841,P31749,Q13131,P49840,P06730,P41440,O75955,P31751,Q16539,P46108,P54646 11 |
| Cardiac progenitor differentiation 0.5953154723497613 0.5841440041609215 0.5591234312936708 1.0 1.0 3 Q16539 1 |
| Dna repair pathways full network 0.4516458158410029 0.5772225456281111 0.5637891286476384 1.0 1.0 53 O60934,Q13619,Q9NR33,P18074,Q9UQ84,P56282,P28340,Q9NRF9,P52701,P54727,Q13426,Q07864,P41440,Q9BXW9,P15927,Q9UGN5,P18887,P12956 18 |
| Nrp1triggered signaling pathways in pancreatic cancer 0.3913345315603352 0.5724620494662769 0.5670089892907524 1.0 1.0 13 P49840,Q9UIW2,P31749 3 |
| Nucleotidebinding oligomerization domain nod pathway 0.405255315794547 0.56264875531287 0.5736740853939652 1.0 1.0 11 P55210,Q9Y6K9,P98170,O15111 4 |
| Biomarkers for pyrimidine metabolism disorders 0.4621279474604106 0.5597905371692414 0.5756223189093799 1.0 1.0 6 P31350 1 |
| Il2 signaling pathway 0.4099392360507998 0.549921830319565 0.5823729903523196 1.0 1.0 10 P62993,P40763,P31749 3 |
| Neural crest cell migration in cancer 0.4166480111641153 0.549513631906256 0.5826530120841635 1.0 1.0 9 Q99523,P31751,P31749 3 |
| Wnt signaling pathway and pluripotency 0.3679908208960759 0.5393294494064407 0.5896595519612959 1.0 1.0 15 P49841,Q9H0H5,P17252,P30154,P30153 5 |
| Angiogenesis 0.4826310210235049 0.5208545198489812 0.6024681199328037 1.0 1.0 5 Q16539 1 |
| Nongenomic actions of 125 dihydroxyvitamin d3 0.4031528284144897 0.516750553894896 0.6053303009006341 1.0 1.0 10 P28702,Q15648,Q16539 3 |
| Mesodermal commitment pathway 0.3653057276668933 0.5149192421367729 0.6066094540303815 1.0 1.0 20 Q9UPN3,P17252,P10644,O75717,Q9Y2X9,Q16527,Q16204 7 |
| Pi3kaktmtor signaling pathway and therapeutic opportunities 0.4504671106747536 0.5123552172527792 0.6084024269443933 1.0 1.0 6 P49841,O75143,P31749 3 |
| Kallmann syndrome 0.5089316371561949 0.5061716216549688 0.6127361749871045 1.0 1.0 4 P62993 1 |
| Nucleotide excision repair in xeroderma pigmentosum 0.4072900116045268 0.5022999261355202 0.6154565611817431 1.0 1.0 38 Q9NR33,Q13619,P56282,P28340,Q9NRF9,P84243,P54727,Q13098,Q07864,P41440,P18887 11 |
| Nanoparticlemediated activation of receptor signaling 0.434276919680018 0.5010587753085758 0.6163297587399446 1.0 1.0 7 P62993 1 |
| Transsulfuration pathway 0.4200918884831069 0.4990499163776388 0.6177442192758265 1.0 1.0 8 P32929,P25325,Q99707 3 |
| Neurodegeneration with brain iron accumulation nbia subtypes pathway 0.3840833004999652 0.4933932777305146 0.6217347312736314 1.0 1.0 12 O15269,Q13131,O75143,Q9NT62,Q96B36,Q9NQ11,Q13057 7 |
| Allograft rejection 0.3755281321670053 0.4890412736437305 0.6248124765976459 1.0 1.0 13 P30511 1 |
| Factors and pathways affecting insulinlike growth factor igf1akt signaling 0.3983257473296931 0.4631102755912752 0.6432853249561061 1.0 1.0 9 Q96B36,P06730,P49770,P31749 4 |
| Glycogen synthesis and degradation 0.3501544662379331 0.4592622733630848 0.6460458361660928 1.0 1.0 18 P49841,P35573,P63151,P30154,P49840,P06737,P13807,P30153 8 |
| Gammaglutamyl cycle for the biosynthesis and degradation of glutathione including diseases 0.7378725891291573 0.4459499501233853 0.6556333997185602 1.0 1.0 2 O75223 1 |
| Melanoma 0.3501833517381332 0.4415301571869246 0.658829234157932 1.0 1.0 15 P62993,P11802,P31749 3 |
| Breast cancer pathway 0.3597753610092497 0.4397060775311632 0.6601500002414897 1.0 1.0 23 P62993,O60934,P49841,Q16611,P63208,P11802,P31749,P42345,P31751,P48729 10 |
| Network map of sarscov2 signaling pathway 0.3797663898180474 0.4396411222050722 0.6601970521746572 1.0 1.0 31 P06493,P31749,P42574,Q14240,P42345,P06730,O75143,O95067,Q9Y6K9,Q08380,Q96B36,Q9UGN5,Q9P253,Q96J02,P31350 15 |
| Pregnane x receptor pathway 0.4565662474407614 0.4265968673789848 0.6696729798081087 1.0 1.0 5 P62195,P07900,O15439,Q99615 4 |
| Cysteine and methionine catabolism 0.4279263331819394 0.4242476767561721 0.6713851937864317 1.0 1.0 6 P32929,P25325,Q99707 3 |
| Tryptophan metabolism 0.3463097321038693 0.4209341676011704 0.6738031545453071 1.0 1.0 15 Q15392 1 |
| Endochondral ossification 0.3884548826221564 0.4180909060396831 0.6758806536481217 1.0 1.0 9 Q9Y496,Q9Y376,P31749 3 |
| Endochondral ossification with skeletal dysplasias 0.3884548826221564 0.4180909060396831 0.6758806536481217 1.0 1.0 9 Q9Y496,Q9Y376,P31749 3 |
| Tcell activation sarscov2 0.3598356844470879 0.4095289946771794 0.6821514931259682 1.0 1.0 13 P62993,P49841,O15111,P31749,P42345,Q9Y6K9 6 |
| Translation inhibitors in chronically activated pdgfra cells 0.346115476055589 0.4078528825824742 0.6833816863998745 1.0 1.0 20 P17252,P31749,P06730,P31751,Q16539,Q14240 6 |
| Epo receptor signaling 0.3987638416494692 0.4066564759419308 0.6842603114898433 1.0 1.0 8 P62993,P40763,P31749 3 |
| Regucalcin in proximal tubule epithelial kidney cells 0.4098856831049604 0.4013712124755048 0.6881468407956914 1.0 1.0 7 P42574,Q16611,P42345,P31749 4 |
| Rac1pak1p38mmp2 pathway 0.3407565764177013 0.3932798411455671 0.6941128056132679 1.0 1.0 19 P62993,O15111,P31749,P55210,Q16539,P46108,P43246 7 |
| Spinal cord injury 0.340606076479638 0.3924745793525197 0.6947075905008164 1.0 1.0 19 P06493,O94813,P11802,P17252,P42574,P14174,P08670,O75116,P04083 9 |
| Map3k1 role in promoting and blocking gonadal determination 0.4740193418967339 0.3920948516481413 0.6949881313717292 1.0 1.0 4 P49841,Q13464 2 |
| Leukocyteintrinsic hippo pathway functions 0.4069791643886474 0.3899451064910568 0.6965771386623854 1.0 1.0 7 Q13043 1 |
| Mitochondrial long chain fatty acid betaoxidation 0.3548764569795612 0.385202032771925 0.7000877374031824 1.0 1.0 13 Q16836,O43772 2 |
| Disruption of postsynaptic signaling by cnv 0.3921307772670002 0.3790307615330121 0.7046650207841725 1.0 1.0 8 Q14168,P61981,P28482,Q7L576 4 |
| Somatroph axis gh and its relationship to dietary restriction and aging 0.7068965517241299 0.3658971498054403 0.7144418232376342 1.0 1.0 2 P31749 1 |
| Il5 signaling pathway 0.3492426312637523 0.3580837967776134 0.7202806044717627 1.0 1.0 13 P62993,P49841,P49840,P31749 4 |
| Nuclear receptors 0.5196424392641934 0.3546415313460954 0.7228581583822007 1.0 1.0 3 P28702 1 |
| Il1 signaling pathway 0.3480208302922044 0.3522786879594855 0.7246292695674532 1.0 1.0 13 Q16539,O15111 2 |
| Novel intracellular components of rigilike receptor rlr pathway 0.3599004422430807 0.3450087717988126 0.7300877762279034 1.0 1.0 11 O15111 1 |
| Pdgf pathway 0.3388079380616769 0.3431013421119344 0.7315222214859229 1.0 1.0 14 O15111 1 |
| Erbb signaling pathway 0.3307710510820085 0.3408891543969035 0.7331870298739969 1.0 1.0 19 P62993,P17252,P31749,P31751,P46108 5 |
| Kit receptor signaling pathway 0.3252167734871691 0.339919338955734 0.7339172725221839 1.0 1.0 17 P62993,P31749,P17252,Q16539,P46108 5 |
| Inclusion body myositis 0.693161893629472 0.3329888778117581 0.7391426787574715 1.0 1.0 2 P05067 1 |
| P38 mapk signaling pathway 0.3787147178271699 0.3250019784030262 0.745179574360032 1.0 1.0 8 P62993 1 |
| H19 action rbe2f1 signaling and cdkbetacatenin activity 0.4258794214945303 0.3247286233696175 0.745386469346268 1.0 1.0 5 Q16527,P11802 2 |
| Serotonin receptor 2 and elksrfgata4 signaling 0.5065770242619283 0.3203921773292781 0.748671054856014 1.0 1.0 3 P27361,P28482 2 |
| Insulin signaling 0.3907483504721803 0.3150512131147993 0.7527227698311292 1.0 1.0 46 P62993,Q9Y496,P49841,P33176,P31749,P17252,Q13131,P49840,P06730,O60343,P41440,Q6ZWJ1,O75955,P31751,Q16539,P46108,P54646,Q96PE3 18 |
| Osteoblast differentiation and related diseases 0.3515968356284665 0.3084721998652684 0.7577230508286932 1.0 1.0 11 Q05655,P42224,P17252,O00443,O00459,Q16539,P28482,P78527,Q99570,P27361 10 |
| Rett syndrome causing genes 0.3380667251545202 0.3060563404008569 0.7595617491201392 1.0 1.0 13 P49770 1 |
| Zinc homeostasis 0.4183230186085407 0.3014082580605999 0.7631031979238474 1.0 1.0 5 Q8NEW0 1 |
| Parkinsons disease pathway 0.3570336108242629 0.2837534487065973 0.7765993312617725 1.0 1.0 9 P55210,Q16539,Q99700 3 |
| Epithelial to mesenchymal transition in colorectal cancer 0.319734325457503 0.2601064869810894 0.7947816342184368 1.0 1.0 21 P62993,P31749,Q16625,P31751,Q16539,P15924 6 |
| Physiological and pathological hypertrophy of the heart 0.3800513503010615 0.2573251116226914 0.7969278087137466 1.0 1.0 6 P40763,Q16539 2 |
| Inhibition of exosome biogenesis and secretion by manumycin a in crpc cells 0.3591920374707307 0.2513564250902728 0.8015385541217601 1.0 1.0 8 Q8WUM4,P28482,P31943,P61020,P20339,P27361,P51148 7 |
| Microglia pathogen phagocytosis pathway 0.4154970760233849 0.2305961713030996 0.8176285423168881 1.0 1.0 4 P60763,O00459,P63000 3 |
| Hedgehog signaling pathway wp47 0.4139239186717419 0.2268609062928717 0.8205319017550086 1.0 1.0 4 Q2M1P5 1 |
| 16p112 distal deletion syndrome 0.3422630224034684 0.2262792999481406 0.8209841971356668 1.0 1.0 9 P62993 1 |
| Intracellular trafficking proteins involved in cmt neuropathy 0.3311258806376333 0.2240193915909973 0.8227422143547554 1.0 1.0 11 Q13614,P07196,Q9NR77 3 |
| Regulation of actin cytoskeleton 0.3634077670833696 0.2230957544104634 0.8234609825825017 1.0 1.0 42 Q96F07,P12814,Q14185,O75116,Q9NYB9,Q9UQB8,Q13464,P46108,O14974 9 |
| Cell migration and invasion through p75ntr 0.367658494431511 0.2196155371752817 0.8261705898975571 1.0 1.0 6 P31751,P31749 2 |
| Netrinunc5b signaling pathway 0.3046027245779011 0.219184517635639 0.8265063154032202 1.0 1.0 15 P31749,P42574,P17252,P30154,Q16539,P28482 6 |
| Integrinmediated cell adhesion 0.3282115120384011 0.215498007815808 0.8293790651119624 1.0 1.0 28 P62993,P31749,P07384,Q14185,O75116,P46108 6 |
| Microtubule cytoskeleton regulation 0.3063503769034501 0.2108855861080531 0.8329765518213064 1.0 1.0 20 P06493,Q15691,P49841,P17252,P31749,P40763,Q13464 7 |
| Mirna regulation of prostate cancer signaling pathways 0.3363148143604303 0.2043203775820168 0.8381031468430231 1.0 1.0 9 Q9Y6K9,P62993,P49841,P42345 4 |
| Embryonic stem cell pluripotency pathways 0.3197948795686228 0.202229039568946 0.8397376718194722 1.0 1.0 12 P62993,P49841,P31749,P40763,P42345,P31751 6 |
| Eicosanoid synthesis 0.6259497369959013 0.1977327249001135 0.8432541844227761 1.0 1.0 2 Q9H7Z7 1 |
| Corticotropinreleasing hormone signaling pathway 0.3053426216365552 0.1947623980136925 0.84557896056324 1.0 1.0 21 P07900,P49841,P17252,P42574,P31749,Q16539,P54646,P42892 8 |
| Interleukin11 signaling pathway 0.2984143758105412 0.1929743731749425 0.8469790380912794 1.0 1.0 15 P62993,O15111 2 |
| G1 to s cell cycle control 0.3153224215635967 0.1811993942380769 0.856211070059832 1.0 1.0 26 P06493,P11802,Q9Y619,P56282,Q07864,P49736,P15927,P33993,P49642,P49643,Q14566 11 |
| Neural crest cell migration during development 0.3381579269002793 0.179601159142236 0.8574656946165016 1.0 1.0 8 P31751,P40763,Q13177,P31749 4 |
| Kisspeptinkisspeptin receptor system in the ovary 0.329249249788373 0.1791826965344108 0.8577942500090083 1.0 1.0 9 P31751,P31749 2 |
| Glial cell differentiation 0.6136762127410834 0.1779330663808223 0.8587755419741796 1.0 1.0 2 P26038 1 |
| Fragile x syndrome 0.3580284922316065 0.1776325212195108 0.8590115824534701 1.0 1.0 44 P62993,Q96F07,Q9Y4R8,P31749,P17252,Q99961,P10644,P53985,P06730,P28288,P09496,P05067,P09497,Q96B36,P50570,P51648,Q7L576 17 |
| Retinoblastoma gene in cancer 0.3690017908140023 0.1775501342239352 0.8590762892932369 1.0 1.0 49 P00374,P11802,Q9Y619,P56282,P04818,Q07864,O95067,Q16204,P15927,P31350 10 |
| Male infertility 0.3011843661881741 0.1770135940144861 0.859497711717232 1.0 1.0 21 P41440,Q15165 2 |
| Ebola virus infection in host 0.3525407480485308 0.1733969247128018 0.8623394422170074 1.0 1.0 42 Q9UN37,P31749,P30511,P41440,P09496,O15118,P10321,Q99816,O75569,P46934 10 |
| Dna replication 0.3255750642455549 0.1706883682564736 0.8644688093920292 1.0 1.0 31 P41440,Q9Y619 2 |
| Pi3kaktmtor vitd3 signaling 0.3494621844671092 0.1690019016554355 0.8657951456116879 1.0 1.0 6 P54646,P49841,P31749 3 |
| Met in type 1 papillary renal cell carcinoma 0.304265771119697 0.1676447379096514 0.8668627734820782 1.0 1.0 23 P62993,Q92733,P46108,P31749 4 |
| Glioblastoma signaling pathways 0.2933766607040994 0.1669794101025765 0.8673862498184404 1.0 1.0 19 P62993,P11802,P31749,P52701,P31751 5 |
| Il6 signaling pathway 0.3031549922394653 0.1614512065586767 0.8717380386268312 1.0 1.0 13 P62993,P49841,P31749 3 |
| Influence of laminopathies on wnt signaling 0.319040134390441 0.1603189970806627 0.872629794919028 1.0 1.0 10 P48729,P49841,O75844 3 |
| Lipid metabolism pathway 0.2961466125536318 0.1580306719542797 0.8744326296647391 1.0 1.0 14 P31749,P17252,P10644,P53396,P31751,P54646 6 |
| Photodynamic therapyinduced ap1 survival signaling 0.3301571254235155 0.1545997609093882 0.8771368584974883 1.0 1.0 8 P07900,Q07820,Q16539 3 |
| Thyroid stimulating hormone tsh signaling pathway 0.2881202659204965 0.1458361815501583 0.8840507124944366 1.0 1.0 19 Q15361,Q16539,P11802 3 |
| Alpha 6 beta 4 signaling pathway 0.2862318115283379 0.1446893332249756 0.8849561613843158 1.0 1.0 15 P62993,Q16539,P31749 3 |
| Type ii diabetes mellitus 0.3730994152046798 0.1423185567320064 0.8868283895659501 1.0 1.0 4 O00330,P42345,P28482 3 |
| Overlap between signal transduction pathways contributing to lmna laminopathies 0.2863489045330409 0.1224524811900203 0.9025406772142652 1.0 1.0 14 P48729,O75844,P55209 3 |
| Dna damage response 0.2950510619090858 0.1204777990271589 0.9041046653439108 1.0 1.0 24 O60934,P11802,O95067,P41440,Q9BXW9,P15927 6 |
| Envelope proteins and their potential roles in edmd physiopathology 0.27540179068007 0.1184739544599426 0.9056921310654475 1.0 1.0 17 Q14739,P62993,O94901 3 |
| Splicing factor nova regulated synaptic proteins 0.2784798458640928 0.1163782603281161 0.9073527640536352 1.0 1.0 15 Q9BY67,P20020 2 |
| Pi3kakt signaling pathway 0.3477265979754382 0.1142778701535032 0.9090175246207745 1.0 1.0 46 P62993,P49841,P11802,P31749,P17252,O15111,P30154,Q13131,Q07820,P06730,P63151,Q16822,P31751,Q16543,Q16513,P54646,P30153 17 |
| Pancreatic adenocarcinoma pathway 0.2954879300398777 0.1121138337956773 0.910733148798333 1.0 1.0 25 Q16611,P11802,P31749,O15111,P40763,P42345,Q9Y6K9,P31751 8 |
| Amyotrophic lateral sclerosis als 0.3031163669014614 0.1086378682880177 0.913489723944634 1.0 1.0 10 Q16539 1 |
| Tgfbeta receptor signaling 0.350877192982459 0.1065871281408282 0.9151165306627054 1.0 1.0 4 P27361,P40763,P42224 3 |
| Tgfbeta receptor signaling in skeletal dysplasias 0.350877192982459 0.1065871281408282 0.9151165306627054 1.0 1.0 4 P27361,P40763,P42224 3 |
| Tgfbeta signaling in thyroid cells for epithelialmesenchymal transition 0.3372077854264874 0.1049184524883213 0.9164405168112983 1.0 1.0 5 P08670,P31749 2 |
| Physicochemical features and toxicityassociated pathways 0.2700560673259475 0.099369785235504 0.920844671891391 1.0 1.0 17 P62993,P31749,O75116,P07196,P35080 5 |
| Phosphoinositides metabolism 0.3180277071316338 0.0959233979887897 0.923581411358352 1.0 1.0 6 Q13614 1 |
| Copper homeostasis 0.3002766970924881 0.0877688094865764 0.930060428491357 1.0 1.0 9 P05067,P49841,P98170,P31749 4 |
| Mirna regulation of dna damage response 0.2874681292389403 0.0832986845206673 0.9336140462614636 1.0 1.0 25 P30307,O60934,P11802,O95067,P41440,Q9BXW9,P15927,P33993 8 |
| Oligodendrocyte specification and differentiation leading to myelin components for cns 0.5143191116306156 0.0719039762761728 0.94267832563237 1.0 1.0 2 P09543 1 |
| Notch signaling pathway 0.2588555679003989 0.0716135210486666 0.9429094794640948 1.0 1.0 16 P49841,P63208,P31749,P40763,Q13642,Q96J02,O75446 7 |
| Gdnfret signaling axis 0.3507746273019605 0.0703694413861842 0.9438996131760632 1.0 1.0 3 O94813,Q9BW83 2 |
| Gpr143 in melanocytes and retinal pigment epithelium cells 0.3493130663548662 0.0693711760327229 0.9446941718252316 1.0 1.0 3 P32121,P17252 2 |
| Mapk pathway in congenital thyroid cancer 0.5064289888953647 0.0671541948924897 0.9464589499429044 1.0 1.0 2 P27361 1 |
| Hippo signaling regulation pathways 0.2578775489982552 0.0596363476922406 0.9524452686021878 1.0 1.0 17 Q13043,P54646,P10644,P17252 4 |
| Bdnftrkb signaling 0.2940380580555111 0.0590393806420802 0.9529207415845792 1.0 1.0 8 P62993,P42345,P31749 3 |
| Endometrial cancer 0.2711698461510652 0.057723378868609 0.9539689710979338 1.0 1.0 13 P62993,P49841,Q16611,P31749,P31751 5 |
| Atr signaling 0.4766218585622347 0.0529891193783661 0.9577405770130032 1.0 1.0 2 P27694 1 |
| Folatealcohol and cancer pathway hypotheses 0.4257744009351161 0.0395377675425278 0.968461642900805 1.0 1.0 2 Q99707 1 |
| Thermogenesis 0.2836588506986329 0.0359178027021898 0.9713479005226264 1.0 1.0 29 P62993,Q9UKU0,O43772,Q96B36 4 |
| Serotonin and anxiety 0.3886616014026828 0.0352012998883014 0.9719192257140536 1.0 1.0 2 Q06787 1 |
| Mir124 predicted interactions with cell cycle and differentiation 0.2989479836353045 0.0325121123682669 0.9740636568637526 1.0 1.0 2 Q13131 1 |
| Ras signaling 0.2849191612967162 0.0315556716160951 0.974826394694331 1.0 1.0 30 P62993,O15111,P31749,P31751,Q13043,Q96KP1 6 |
| G protein signaling pathways 0.2477252714998532 0.0306176163985613 0.9755744928814702 1.0 1.0 17 P29992,Q05655,O60658,Q92888,P13861,Q99996,P17252,P10644,Q08209,P08754,Q9UBI6,P17612,Q14344,Q92667,P63218,O43823 16 |
| Nicotine effect on dopaminergic neurons 0.2450292397660852 0.0234258384494162 0.981310594556862 1.0 1.0 4 Q00535,P17612,P17252 3 |
| Mbdnf and probdnf regulation of gaba neurotransmission 0.2742171495463764 0.0203510757734256 0.983763311633874 1.0 1.0 7 P63010,O94973,P40763,O00459,Q13464,P19174 6 |
| Leptin signaling pathway 0.2830100490399492 0.0180014266588163 0.9856377152870142 1.0 1.0 31 P62993,P49841,O15111,P31749,Q13131,P49840,P06730,O75116,Q16539,Q13464,P54646 11 |
| Small cell lung cancer 0.2464080646843231 0.0118943742859057 0.9905098861681711 1.0 1.0 19 P63208,P11802,P31749,P42574,O15111,Q9Y6K9,P31751,P28702 8 |
| Dna damage response only atm dependent 0.2478894307519593 0.000948039241583 0.9992435742394156 1.0 1.0 21 P62993,P31751,Q16822,P31749 4 |
| Sterol regulatory elementbinding proteins srebp signaling 0.2850426532014391 0.0009072472100995 0.999276121557534 1.0 1.0 34 Q15436,P31749,P17252,Q8WTV0,Q13131,P49840,Q16850,P53396,Q9UKV5,P14324,P54646 11 |
|
|
